Dirk Hessel

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation.

Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.

Bauerfeind AG manufactures supports and orthoses, as well as medical compression stockings and insoles. The company was founded in 1929 and is headquartered in Zeulenroda-Triebes, Germany.

Part of Bauerfeind AG, Bauerfeind USA, Inc. wholesales orthopaedic goods through online. The company is based in Marietta, GA.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development.

International Biotech Center Generium, LLC operates as a Russian scientific research company.

Part of co.don AG, co.don schweiz GmbH operates as a Swiss biopharmaceutical company. The company is based in Zug, Switzerland. The CEO of the company is Tilmann Heinrich Johannes Bur.

Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY.

Actigen Ltd. provides biological products. The private company is based in Cambridge, UK.

Bio-Seehotel Zeulenroda GmbH & Co. KG is a private company based in Zeulenroda-Triebes, Germany. The German company is led by CEOs Hans B. Bauerfeind and Marco Lange.

Part of Bauerfeind AG, Uniprox GmbH & Co. KG is a German company that specializes in producing orthoses and prosthetic sockets made of epoxy resin. The company is based in Zeulenroda-Triebes, Germany. The company's Orthopoxy® products are BPA-free, highly durable, and visually appealing. The CEOs of the company are Hans B. Bauerfeind and Ingo Schneider. Uniprox is a leading supplier of orthopedic technology, offering prostheses and accessories for leg amputations, orthoses for hands, back, and more. The company also provides specialized tools and materials, and their model service ensures efficient processes. Customers can contact their customer service, technical service, or field service for detailed advice and support.